• / Free eNewsletters & Magazine
  • / My Account
Home>Frazier Healthcare Partners Adds Experienced Global Biotech and Pharma Executive Mark Barrett to Life Sciences Team

Frazier Healthcare Partners Adds Experienced Global Biotech and Pharma Executive Mark Barrett to Life Sciences Team

Frazier Healthcare Partners Adds Experienced Global Biotech and Pharma Executive Mark Barrett to Life Sciences Team

09/28/2017

Frazier Healthcare Partners Adds Experienced Global Biotech and Pharma Executive Mark Barrett to Life Sciences Team

Frazier Healthcare Partners announced today that Mark Barrett has joined the Life Sciences team as an Entrepreneur-in-Residence (EIR). Most recently, Mr. Barrett served as Global Head of Strategy & Business Development at Sanofi Genzyme and was a member of the company’s executive leadership team responsible for managing Sanofi Genzyme’s global rare diseases, immunology, multiple sclerosis, and oncology businesses. Prior to Genzyme, Mr. Barrett held leadership positions in Johnson & Johnson’s business development group and helped launch the Johnson & Johnson Innovation Center in Boston.

Mr. Barrett brings more than 15 years of leadership and biopharma industry expertise to his efforts to form new companies with Frazier. He is the founder and CEO of Yosemite Therapeutics, a newly formed search company focused on developing innovative treatments for serious diseases, and will be based in Boston.

“We have known Mark for many years and worked closely with him on the successful spin-out of Incline Therapeutics from J&J. We are thrilled to have him join our company creation efforts,” said Jamie Topper, Managing General Partner with the Frazier Life Sciences team.

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $3.0 billion total capital raised, Frazier has invested in over 170 companies, with investment types ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, WA and Menlo Park, CA, and invests broadly across the US, Canada, and Europe.

For more information about Frazier Healthcare Partners, visit the company's website at http://www.frazierhealthcare.com.

About Yosemite Therapeutics

©2017 Morningstar Advisor. All right reserved.